Accelerating Medicines Partnership® SCHIZOPHRENIA
For Scientists
Using data from a non-interventional study, the Accelerating Medicines Partnership (AMP®) SCZ program seeks to build tools to improve success in developing pharmacologic treatments for patients with clinical high risk for psychosis.

Protocols


Click below to download a Protocol Summary Flyer.

Accelerating Medicines Partnership® Schizophrenia
Protocol Summary

 


Last Reviewed on May 2, 2022